Does sex matter? Temporal analyses of melanoma trends among men and women suggest etiologic heterogeneity.

anatomic site incidence melanoma sex

Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
17 Jun 2024
Historique:
received: 16 01 2024
revised: 04 04 2024
accepted: 07 05 2024
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 19 6 2024
Statut: aheadofprint

Résumé

The incidence and distribution of cutaneous melanoma differs between the sexes, but it is unclear whether these differences have been constant through time or across generations. We compared incidence trends by age, sex, and anatomic site by analyzing long-term melanoma data (1982-2018) in three populations residing at high-, moderate- and low- ambient sun exposure: Queensland, Australia; United States White; Scotland. We fit age-period-cohort models and compared trends in the male-to-female incidence rate ratio (IRR) by site and sex. In men, melanoma incidence was always highest on the trunk; in women, incidence was historically highest on limbs, but there have been recent increases in truncal melanoma among females in all populations. The IRR showed excess melanoma in females on the lower limb in most age groups in all populations. In contrast, there was a male excess of melanoma on the trunk (from about age 25 years) and head/neck (from about age 40 years) which increased with age. Birth cohort analyses identified 'turning points' in incidence from high to low incidence among recent birth cohorts, which differed by population and site. Changing exposure to UV radiation is implicated, possibly superimposed upon innate differences between the sexes in site-specific susceptibility.

Identifiants

pubmed: 38897542
pii: S0022-202X(24)01500-8
doi: 10.1016/j.jid.2024.05.011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Published by Elsevier Inc.

Auteurs

Catherine M Olsen (CM)

Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Nirmala Pandeya (N)

Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Adalberto Miranda-Filho (A)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

Philip S Rosenberg (PS)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

David C Whiteman (DC)

Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Australia. Electronic address: David.Whiteman@qimrberghofer.edu.au.

Classifications MeSH